Efficacy and safety of tregalizumab in patients with rheumatoid arthritis and an inadequate response to methotrexate: results of a phase IIb, randomised, placebo-controlled trial.
| Author | |
|---|---|
| Abstract | :
To evaluate the efficacy, biological activity and safety of tregalizumab in patients with active rheumatoid arthritis (RA) and an inadequate response to methotrexate (MTX). |
| Year of Publication | :
2018
|
| Journal | :
Annals of the rheumatic diseases
|
| Date Published | :
2018
|
| ISSN Number | :
0003-4967
|
| URL | :
http://ard.bmj.com/cgi/pmidlookup?view=long&pmid=29343509
|
| DOI | :
10.1136/annrheumdis-2017-212478
|
| Short Title | :
Ann Rheum Dis
|
| Download citation |